Call for Abstract

3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, will be organized around the theme “Exchange & Translation of Scientific Information on Preventive Oncology”

Gynec & Preventive Oncology 2017 is comprised of 22 tracks and 229 sessions designed to offer comprehensive sessions that address current issues in Gynec & Preventive Oncology 2017.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Predictive oncology basically advances essential growth aversion by evaluation of tumor defencelessness and control of genotoxic exposures and of the fundamental components that may prompt the improvement of neoplastic ailments. Prescient oncology fuses likewise distinguishing proof of malignancy inclined people and prognostic assessment of tumor improvement and movement and in addition way of life change.

  • Track 1-1Role of Multistage Cofactorial Exposures
  • Track 1-2Diagnostic
  • Track 1-3Cancer chemo prevention
  • Track 1-4Cancer Biomarkers
  • Track 1-5Clinical and laboratory aspects of cancer detection
  • Track 1-6Assessment Of Exposure to Carcinogens
  • Track 1-7Genetic Markers
  • Track 1-8Prediction Of Response to Anticancer Therapies
  • Track 1-9Prognostic Assessment of Occult, Incipient And Advanced Neoplasms
  • Track 1-10Genetic Predisposition to Cancer
  • Track 1-11Molecular Biology of Cancer Susceptibility
  • Track 1-12Identification of Avoidable Risk Factors
  • Track 1-13Introduction to Oncogenomics

Preventive oncology for auxiliary counteractive action concentrates on routine clinical and research centre techniques for early identification and treatment of growth, patient administration and instruction, administration of reparable sores, training and way of life adjustment. Counteractive action of tumor can happen on a few unique levels: essential aversion addresses the reason for growth so ailment does not happen, optional avoidance recognizes sickness before the onset of side effects and keeps it from turning out to be more broad, and tertiary anticipation lessens difficulties and movement of ailment once it has turned out to be clinically clear. Preventive oncology for secondary prevention of cancer involves:

  • Track 2-1Screening modalities and their cost effectiveness
  • Track 2-2Public awareness and professional education
  • Track 2-3Methodological issues of cancer detection
  • Track 2-4Screening guidelines for cancer detection
  • Track 2-5Management of patients with preneoplastic alterations
  • Track 2-6Management of early curable neoplasms
  • Track 2-7Novel therapeutic approaches

A cancer cell is a cell that becomes crazy. Not at all like typical cells, have malignancy cells overlooked signs to quit isolating, to practice, or to pass on and be shed. Developing in a wild way and not able to perceive its own particular regular limit, the tumor cells may spread to territories of the body where they don't have a place.

In a malignancy cell, a few qualities change (transform) and the cell gets to be flawed. There are two general sorts of quality transformations. One write, prevailing change, is brought about by a variation from the norm in one quality in a couple. The second broad kind of transformation, latent change, is described by both qualities in the pair being harmed.

  • Track 3-1Cancer Biology
  • Track 3-2Cellular Pathology
  • Track 3-3Cancer Metabolosim
  • Track 3-4Cancer Nanotechnology
  • Track 3-5Cancer Genetics
  • Track 3-6Cancer risk factor

Malignancy has a differentiated nature in connection to the organ specificity. The essential center is on heterogeneity, starting point, metastasis, angiogenesis and organ indicated systems in disease cells. There are diverse sorts of diseases taking into account area of tumor in the body organ. Organ-particular metastasis includes disease cell collaborations with the host microenvironment, including actuation of paracrine cytokine circles, change of the host cell sythesis, and modification of extracellular framework structures. Resistant cell avoidance, relationship with a strong specialty, and the capacity to open up survival pathways, frequently accomplished through association with the stroma, are vital for fruitful metastatic colonization.

  • Track 4-1Multistage Carcinogenesis
  • Track 4-2Heart cancer
  • Track 4-3Gynaecological Cancer
  • Track 4-4Endometrial cancer
  • Track 4-5Hemato-Oncology
  • Track 4-6Neuroblastoma
  • Track 4-7Oncology Cachexia
  • Track 4-8Ocular Melanoma
  • Track 4-9Osteosarcoma
  • Track 4-10Skin Cancer
  • Track 4-11Pediatric cancer
  • Track 4-12Neuro-Oncology
  • Track 4-13Urology Oncology
  • Track 4-14Otolaryngology cancers
  • Track 4-15Oral cancer
  • Track 4-16Thyroid Cancer
  • Track 4-17Gastrointestinal Cancer
  • Track 4-18Lung cancer
  • Track 4-19Renal cancer
  • Track 4-20Oncology : Psychological & Social Aspects

The most recent energizing examination leap forward for disease treatment is in the field of immuno-oncology. This type of treatment uses or upgrades the patient's own particular insusceptible framework to have the capacity to stop the development of malignancy cells.

The insusceptible framework is the body's common barrier framework. It is an accumulation of organs, cells and exceptional atoms that shields you from contaminations, tumor and different maladies. At the point when an alternate (remote) life form goes into the body, for instance a microscopic organisms, the resistant framework remembers it and after that assaults it, keeping it from creating hurt. This procedure is called an insusceptible reaction. Since malignancy cells are altogether different from typical cells in the body, the resistant framework assaults them when it can remember them. Notwithstanding, disease cells regularly discover approaches to mask themselves as typical cells, so that the safe framework does not generally remember them as unsafe. What's more, like infections, they can change after some time (transform) and hence escape from the insusceptible reaction. Additionally, the characteristic safe reaction to disease cells is frequently not sufficiently solid to battle off growth cells. Immuno-oncology treatments enact our insusceptible framework, making it ready to perceive growth cells and decimate them.

  • Track 5-1Tumor immunology
  • Track 5-2Immune suppression
  • Track 5-3Antitumour
  • Track 5-4Tumour-associated antigens
  • Track 5-5Tumour microenvironment
  • Track 5-6Enhancing Adaptive Anti-Tumor Responses
  • Track 5-7Prediction and Prognosis in Immunotherapy
  • Track 5-8Preclinical and clinical development
  • Track 5-9Cell and gene therapy
  • Track 5-10Immunology
  • Track 5-11Biomarker discovery
  • Track 5-12Antibody and protein engineering
  • Track 5-13Immuno-resistive drugs
  • Track 5-14Immunosurveillance

Pediatric oncology is a quality control in medication worried with diagnosing and treating kids, when in doubt up to the age of 18, with danger. It is thought to be a standout amongst the most difficult of claims to fame in light of the fact that, in spite of fruitful treatment of numerous kids, there is a high passing rate still associated with various sorts of malignancies.

  • Track 6-1Types of Pediatric Oncology
  • Track 6-2Pleuropulmonary Blastoma
  • Track 6-3Germ Cell Tumor
  • Track 6-4 Retinoblastoma
  • Track 6-5Non-Hodgkin lymphoma
  • Track 6-6Wilms tumor
  • Track 6-7Neuroblastoma
  • Track 6-8Pediatric Hematology Oncology
  • Track 6-9Clinical Pediatrics
  • Track 6-10Pediatric Cancer Care
  • Track 6-11Pediatric Oncology Nursing
  • Track 6-12Pediatric Oncology Treatment
  • Track 6-13Pediatric Oncology Diagnosis
  • Track 6-14Pediatric Neuro- Oncology
  • Track 6-15Pediatric Radiology
  • Track 6-16Pediatric Leukemia
  • Track 6-17Hepatoblastoma

Molecular and Cellular Oncology's main goal is to improve essential exploration incredibleness by setting up a solid examination bunch concentrated on the sub-atomic and cell parts of growth exploration, especially in sub-atomic and cell flagging pathways for tumor movement and metastasis; to upgrade translational exploration for advancement of focused malignancy treatments; to improve instructive projects for cutting edge researchers.

  • Track 7-1Cell and Molecular Pharmacology & Experimental Therapeutics
  • Track 7-2Genetic
  • Track 7-3Epigenetic
  • Track 7-4Biochemical
  • Track 7-5Oncogene signalling
  • Track 7-6Metabolism
  • Track 7-7Angiogenesis

Surgery was the main treatment for disease with spearheading specialists pushing the limits of learning down through the millenia. Surgery is still the main methodology with the possibility to cure most strong diseases. Specialists have a critical part in growth medicines and research, driving the indicative and treatment pathways for most tumors from directing patients about their determination through to surgery and aftercare. They have likewise driven large portions of the considerable advances in tumor research.

Never again is surgery alone the main treatment for most strong malignancies however a mix of surgery and multi-modular treatments (with exceptionally focussed radiotherapy, focused on atomic treatments and poly-chemotherapy) turning into the cutting edge standard of consideration.

  • Track 8-1Multi-modal therapies
  • Track 8-2Oncoplastic surgery
  • Track 8-3Colostomy
  • Track 8-4Endoscopy
  • Track 8-5Endoscopy
  • Track 8-6Lumpectomy
  • Track 8-7Lung cancer surgery
  • Track 8-8Advances in surgical oncology
  • Track 8-9Chemo prevention in clinical trials

Anticancer medications are utilized to treat malignancies, or dangerous developments. Drug treatment might be utilized alone, or in mix with different medicines, for example, surgery or radiation treatment Anti-malignancy medications are utilized to control the development of carcinogenic cells. Malignancy is normally characterized as the uncontrolled development of cells, with loss of separation and ordinarily, with metastasis, spread of the growth to different tissues and organs. Tumors are threatening developments. Interestingly, benevolent developments remain embodied and develop inside a very much characterized region. Albeit kind tumors might be lethal if untreated, because of weight on key organs, as on account of an amiable mind tumor, surgery or radiation are the favored techniques for treating developments which have a very much characterized area. Anticancer medications are utilized when the tumor has spread, or may spread, to all regions of the body.

  • Track 9-1Targeted Anticancer Therapies
  • Track 9-2Nanotechnology in cancer drugs
  • Track 9-3Anticancer drugs in global market: economy & their cost effectiveness
  • Track 9-4Novel drug delivery system & cancer drug designing
  • Track 9-5Therapeutic antibodies & cancer vaccines
  • Track 9-6Drugs and mechanism
  • Track 9-7Preventive Oncology Vaccines
  • Track 9-8Preventive Oncology Drugs
  • Track 9-9Preventive Oncology Stem Cell Therapy
  • Track 9-10Preventive Oncology Pharmacology
  • Track 9-11Modern medicine
  • Track 9-12Gene Therapy
  • Track 9-13Radiation Therapy
  • Track 9-14Chemotherapy
  • Track 9-15Cancer Therapy and Clinical Cancer Research
  • Track 9-16Anti-cancer drugs and delivery
  • Track 9-17Anti-Cancer Agents in Medicinal Chemistry
  • Track 9-18Functional genomics in drug discovery & development

A cancer vaccine is an antibody that either treats existing disease or forestalls advancement of a malignancy. Antibodies that regard existing growth are known as restorative malignancy immunizations. Malignancy immunizations help the resistant framework's normal capacity to perceive and annihilate things that are remote and possibly unsafe to the body. A solid, sound resistant framework can distinguish antigens and assault them, ordinarily dispensing with them. A malignancy treatment antibody exploits the resistant framework's reaction to antigens. Regularly, tumor cells have particular particles on their surface that are not present on solid cells. At the point when infused into a man, these particular atoms go about as antigens, which empower the safe framework to perceive and pulverize tumor cells that have these particles on their surface. Most disease antibodies additionally contain adjuvants. Malignancy immunizations are two sorts they are Preventive (or prophylactic) antibodies.

  • Track 10-1Immunotherapy on targeting cancer gene therapy
  • Track 10-2Prophylactic Vaccine
  • Track 10-3Cancer Therapeutic Vaccines
  • Track 10-4Preventive cancer vaccines
  • Track 10-5Immunotherapy of cancer vaccines
  • Track 10-6Research on cancer vaccines
  • Track 10-7Cancer Immuno vaccine

The branch of medication that arrangements with the conclusion and treatment of harm, disfigurement, and infection by the utilization of instruments. Immature microorganism treatment is the utilization of undifferentiated cells to treat or keep an illness or condition. Undifferentiated organisms have colossal guarantee to help us comprehend and treat a scope of illnesses, wounds and other wellbeing related conditions. Their potential is apparent in the utilization of blood undifferentiated organisms to treat ailments of the blood, a treatment that has spared the lives of a great many youngsters with leukemia; and can be found in the utilization of undeveloped cells for tissue unions to treat infections or harm deep down, skin and surface of the eye. Some bone, skin and corneal (eye) wounds and infections can be dealt with by uniting or embedding tissues, and the mending procedure depends on undifferentiated organisms inside this embedded tissue. A bone marrow transplant is a system to supplant harmed or wrecked bone marrow with solid bone marrow undeveloped cells.

  • Track 11-1Surgeries
  • Track 11-2Hormonal Therapy
  • Track 11-3Targeted Therapy
  • Track 11-4LASER and LASIC
  • Track 11-5Immunotherapy
  • Track 11-6Stem cell transplantation
  • Track 11-7Proton therapy
  • Track 11-8Bone marrow Transplantation
  • Track 11-9Stem cells: therapeutic uses
  • Track 11-10Oral stem cell therapy
  • Track 11-11Allogeneic bone marrow transplantation
  • Track 11-12Stem cell replacement
  • Track 11-13Malignant and non-malignant diseases
  • Track 11-14Neurodegeneration
  • Track 11-15Gene Therapy
  • Track 11-16Angiogenesis Inhibitors

Bone marrow transplantation is the strategy to supplant harmed bone marrow cells with solid bone marrow cells of the same individual or in another good individual to reestablish the ordinary generation of platelets. It is otherwise called Hematopoietic undifferentiated organism transplantation (HSCT). It is the transplantation of multipotent hematopoietic undifferentiated cells, typically got from bone marrow, fringe blood, or umbilical line blood. It might be autologous (the patient's own particular foundational microorganisms are utilized), allogeneic (the immature microorganisms originate from a giver) or syngeneic ( from an indistinguishable twin ). It is a restorative strategy in the field of hematology, frequently performed for patients with specific malignancies of the blood or bone marrow, for example, numerous myeloma or leukemia. In these cases, the beneficiary's safe framework is typically demolished with radiation or chemotherapy before the transplantation. Contamination and joining versus-host malady are real entanglements of allogeneic HSCT.

  • Track 12-1Autologous Bone marrow Transplantation
  • Track 12-2Allogeneic Bone marrow Transplantation
  • Track 12-3Syngeneic Bone marrow Transplantation

Medical imaging is the method and procedure of making visual representations of the inside of a body for clinical examination and therapeutic intercession, and additionally visual representation of the capacity of a few organs or tissues. Therapeutic imaging tries to uncover interior structures covered up by the skin and bones, and additionally to analyse and treat malady. Medicinal imaging likewise builds up a database of ordinary life structures and physiology to make it conceivable to distinguish variations from the norm. In spite of the fact that imaging of expelled organs and tissues can be performed for medicinal reasons, such methodology is typically considered a portion of pathology rather than restorative imaging.

  • Track 13-1Radiography
  • Track 13-2Echocardiography
  • Track 13-3Tomography
  • Track 13-4Thermography
  • Track 13-5Photoacoustic imaging
  • Track 13-6Tactile imaging
  • Track 13-7Elastography
  • Track 13-8Ultrasound
  • Track 13-9Nuclear medicine
  • Track 13-10Magnetic Resonance Imaging (MRI)
  • Track 13-11Functional near-infrared spectroscopy

A biomarker, or biological marker, generally refers to a measurable indicator of some biological state or condition. The term is also occasionally used to refer to a substance the presence of which indicates the existence of a living organism. Further, life forms are known to shed unique chemicals, including DNA, into the environment as evidence of their presence in a particular location. Biomarker is a characteristic diagnostic tool that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention. Biomarkers can be molecules, or genes, gene products, enzymes, or hormones referred as protein biomarkers, analytical biomarkers, blood biomarkers, fluorescent biomarkers, circulating biomarkers and molecular biomarkers to quantify the degree of disease condition.

  • Track 14-1Protein biomarkers
  • Track 14-2Fluorescent biomarkers
  • Track 14-3Blood biomarkers: Serum and blood cells
  • Track 14-4Analytical biomarkers
  • Track 14-5Genetic Biomarkers
  • Track 14-6Molecular Biomarkers

Medicinal chemistry and pharmaceutical chemistry are disciplines at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with design, chemical synthesis and development for market of pharmaceutical agents, or bio-active molecules (drugs).

Compounds used as medicines are most often organic compounds, which are often divided into the broad classes of small organic molecules (e.g., atorvastatin, fluticasone,clopidogrel) and "biologics" (infliximab, erythropoietin, insulin glargine), the latter of which are most often medicinal preparations of proteins (natural and recombinant antibodies, hormones, etc.). Inorganic and organometallic compounds are also useful as drugs (e.g., lithium and platinum-based agents such as lithium carbonate and cis-platin as well asgallium).

  • Track 15-1Medicinal Chemical Research
  • Track 15-2Anti-Allergic
  • Track 15-3Chemical Biology of Molecules
  • Track 15-4Chemical Pharmacology
  • Track 15-5Bioorganic Medicinal Chemistry
  • Track 15-6Medicinal Companies and Market Analysis
  • Track 15-7Medicinal Biochemistry
  • Track 15-8Anticancer Agents in Medicinal Chemistry
  • Track 15-9Applied Medicinal Chemistry
  • Track 15-10Synthetic Medicinal Chemistry’
  • Track 15-11Medicinal Organic Chemistry
  • Track 15-12Anti-Infective Agents in Medicinal Chemistry

Medical physics (also called biomedical physics, medical biophysics or applied physics in medicine) is, generally speaking, the application of physics concepts, theories and methods to medicine or healthcare. Medical physics departments may be found in hospitals or universities.

In the case of hospital work, the term 'Medical Physicist' is the title of a specific healthcare profession with a specific mission statement. Such Medical Physicists are often found in the following healthcare specialties: 

  • Track 16-1Intervention Radiology
  • Track 16-2Healthcare informatics and computational physics
  • Track 16-3Physics of the human and animal bodies
  • Track 16-4Physiological measurement techniques
  • Track 16-5Cardiophysics
  • Track 16-6Neurophysics
  • Track 16-7Medical optics
  • Track 16-8Laser medicine
  • Track 16-9Clinical audiology physics
  • Track 16-10Health physics
  • Track 16-11Nuclear medicine physics
  • Track 16-12Radiation therapeutic physics
  • Track 16-13Medical imaging physics
  • Track 16-14Radiation Protection
  • Track 16-15Clinical Physiology
  • Track 16-16Areas of research and academic development

Complementary and alternative medicine is also known as CAM. CAM therapies include a wide variety of botanicals and nutritional products, such as dietary supplements, herbal supplements, and vitamins. Many of these "natural" products are considered to be safe because they are present in, or produced by, nature. However, that is not true in all cases. In addition, some may affect how well other medicines work in your body. 

There is research to show that some Complementary and alternative medicine techniques can help with problems like pain and nausea. But other therapies don't have enough medical evidence to decide if they are effective.

  • Track 17-1Homeopathy
  • Track 17-2Holistic health and mind body medicine
  • Track 17-3Chiropractic Medicine
  • Track 17-4Energy Therapies
  • Track 17-5Whole medical systems
  • Track 17-6Manipulative and body-based practices
  • Track 17-7Biologically based practices
  • Track 18-1Clinical implications
  • Track 18-2Oncology Nursing Practice
  • Track 18-3Patient Care Measures
  • Track 18-4Primary Care and Oncology Nursing
  • Track 18-5Oncology Nursing and Cancer care
  • Track 18-6Psychological and psychosocial aspects and Cancer care
  • Track 18-7Effects of Cancer in chemotherapy and Oncology Nursing
  • Track 18-8Oncology Nursing in USA

Oncogenomics is a relatively new sub-field of genomics that applies high throughput technologies to characterize genes associated with cancer. The study involves the research in to the Bioinformatics and functional analysis of oncogenes, which refers to the gene that has the potential to cause cancer. In tumor cells, they are often mutated or expressed at high levels. Cancer genome sequencing requires the development of new techniques utilizing Genomics and bioinformatics tools for target assessment, including both experimental protocols and data analysis algorithms, to enable a deeper understanding of complex biological systems.

Metabolomics is a newborn cousin to genomics and proteomics. Specifically, metabolomics involves the rapid, high throughput characterization of the small molecule metabolites found in an organism. The metabolome is closely tied to the genotype of an organism, its physiology and its environment (what the organism eats or breathes), metabolomics offers a unique opportunity to look at genotype-phenotype as well as.

  • Track 19-1Pharmacology
  • Track 19-2Potential Diagnostic Applications
  • Track 19-3Mutations In Mitochondrial DNA And Cancer
  • Track 19-4Advances From Oncogenomics
  • Track 19-5Databases For Cancer Research
  • Track 19-6Comparative Oncogenomics
  • Track 19-7Bioinformatics And Functional Analysis Of Oncogenes
  • Track 19-8Cancer Transcriptomes
  • Track 19-9Cancer Genome Sequencing
  • Track 19-10Clinical Chemistry
  • Track 19-11Newborn Screening
  • Track 19-12Transplant Monitoring,
  • Track 19-13Toxicology
  • Track 19-14Pre-Clinical Drug Trials
  • Track 19-15Cancer Biomarkers

A prognosis is the doctor's best estimate of how cancer will affect a person. Many factors can affect a person's prognosis. Survival statistics are one tool that doctors use to develop a prognosis for a person with cancer. Doctors often look at studies that measure survival for a particular type of cancer, stage or risk group, when developing a prognosis.

There are different types of cancer survival statistics and different ways to measure and report survival. In general, survival is the proportion of people with cancer who are alive at some point in time (such as 1, 3, 5 or 10 years) after their diagnosis. Prognosis depends on many factors, including:

  • Track 20-1Type of cancer
  • Track 20-2Stage
  • Track 20-3Characteristics of the cancer
  • Track 20-4Treatments chosen
  • Track 20-5Response to treatment

Cancer Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. At Cancer Treatment Centres. We use sophisticated diagnostic technology to pinpoint and evaluate tumors, and develop a personalized treatment plan. Some cancers are diagnosed during routine screening examinations. These are usually tests that are routinely done at a certain age. Many cancers are discovered when you present to your health care professional with specific symptoms.

  • Track 21-1A review of health history
  • Track 21-2Physical examination
  • Track 21-3Laboratory tests (blood, urine, etc.)
  • Track 21-4Biopsy
  • Track 21-5Imaging tests (X-ray, PET/CT, MRI, ultrasound, etc.)
  • Track 21-6Nuclear medicine scans (bone scans, etc.)
  • Track 21-7Endoscopy
  • Track 21-8Genetic tests

As the researchers learn more about cancer, they’re developing new therapies that target particular types of tumor cells and restrict their growth. Blood carcinoma  is one of the major cancer that affect mainly blood, bone marrow, lymph and lymphatic system for treating this recent techniques have been discovered  by the researchers through targeting the tumor and restrict their growth. On their own or in combination with other alternative treatments, these therapies can decrease the size of tumors and symptoms. Some innovative therapies give hope for people with cancers that have been resistant to more treatments.

There are different stages of the cancer like Stage 1, Stage 2, Stage 3 and Stage 4. The Oncology Conference delivers practical ideas, solutions, and strategies to implement in cancer program today. This advance also speaks to the importance of value in cancer care. Value is a major focus for ASCO, because clinical benefit, toxicity, and cost must all be factored into shared decision making to determine the best treatment options for patients. ASCO is working to develop a physician-guided tool that will help patients evaluate new treatment options such as those highlighted in this report.

  • Track 22-1Cancer and lifestyle connection
  • Track 22-2Health education on Cancer prevention
  • Track 22-3Global Cancer Epidemiology
  • Track 22-4Cancer Nanotechnology